# MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer

> clinical trial · VERIFIED · 2026-07-09

Status: ACTIVE_NOT_RECRUITING · Sponsor: Fudan University · Condition: HR Positive/HER-2 Negative Breast Cancer

- Company: Fudan University
- Sector: HR Positive/HER-2 Negative Breast Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07692230

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.